Determination of GHB and GHB-β-O-glucuronide in hair of three narcoleptic patients-Comparison between single and chronic GHB exposure. 2017

Lena-Maria Mehling, and Xin Wang, and Sys-Stybe Johansen, and Annika Spottke, and Anna Heidbreder, and Peter Young, and Burkhard Madea, and Cornelius Hess
Institute of Forensic Medicine, University Hospital Bonn, Stiftsplatz 12, 53111 Bonn, Germany. Electronic address: lena-maria.mehling@ukbonn.de.

Gamma-hydroxybutyric acid (GHB) can be used as a knock-out drug in drug facilitated crime (DFC). Due to its rapid metabolism and resulting narrow detection window, uncovering GHB use in DFC still constitutes a problem. In this experiment we determined the GHB and GHB-β-O-glucuronide (GHB-Gluc) concentrations in hair samples after single and chronic GHB exposures. Hair samples of three narcoleptic patients therapeutically taking sodium oxybate (GHB-sodium-salt) were collected. Patients 1 (P1) and 2 (P2) took the medication for nine and six years, respectively. P1 took daily the pharmaceutical Xyrem® in a total dose of 5.78g GHB at bed time (2.89g) and four hours (2.89g) later. P2 took a dose of 3.10g GHB at bed time and an additional dose of 2.68g GHB four hours later. Patient 3 (P3) was newly diagnosed with narcolepsy and started his therapy with oral dose of 6g (divided in three portions of 2g GHB) within 24h. The hair samples were extracted both with and without forerunning washing steps. GHB and GHB-Gluc were determined by a published ultra-high performance liquid chromatography-tandem mass spectrometry method using GHB-d6 and GHB-Gluc-d4 as internal standards. GHB and GHB-Gluc concentrations in unwashed hair samples of P1 and P2 were determined in a range of 0.56-1.30ng/mg and <0.48-0.85ng/mg, respectively. In washed hair samples of P1 and P2 the concentrations were in a range of <0.32-0.68ng/mg and <0.48-1.20ng/mg for GHB and GHB-Gluc, respectively. The determined concentrations were within the published endogenous range. The confirmed results showed that the washing procedure before extraction causes a minor decrease of GHB concentrations in hair (difference: <1ng/mg). The investigations showed that a single GHB exposure might not be determined by hair analysis of GHB and GHB-Gluc. The chronical intake of therapeutic sodium oxybate with doses up to 7g per night was also not confirmed by hair analysis maybe due to hair treatments. Therefore, GHB hair analysis should be assessed critically and determined negative results could not exclude GHB exposures.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009290 Narcolepsy A condition characterized by recurrent episodes of daytime somnolence and lapses in consciousness (microsomnias) that may be associated with automatic behaviors and AMNESIA. CATAPLEXY; SLEEP PARALYSIS, and hypnagogic HALLUCINATIONS frequently accompany narcolepsy. The pathophysiology of this disorder includes sleep-onset rapid eye movement (REM) sleep, which normally follows stage III or IV sleep. (From Neurology 1998 Feb;50(2 Suppl 1):S2-S7) Gelineau Syndrome,Narcolepsy-Cataplexy Syndrome,Paroxysmal Sleep,Gelineau's Syndrome,Narcoleptic Syndrome,Gelineau's Syndromes,Gelineaus Syndrome,Narcolepsy Cataplexy Syndrome,Narcolepsy-Cataplexy Syndromes,Narcoleptic Syndromes,Sleep, Paroxysmal,Syndrome, Gelineau,Syndrome, Gelineau's,Syndrome, Narcolepsy-Cataplexy,Syndrome, Narcoleptic,Syndromes, Gelineau's,Syndromes, Narcolepsy-Cataplexy,Syndromes, Narcoleptic
D002491 Central Nervous System Agents A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "nonspecific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with nonspecific mechanisms are generally further classed according to whether they produce behavioral depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (From Gilman AG, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p252) Central Nervous System Drugs
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005260 Female Females
D006197 Hair A filament-like structure consisting of a shaft which projects to the surface of the SKIN from a root which is softer than the shaft and lodges in the cavity of a HAIR FOLLICLE. It is found on most surfaces of the body. Fetal Hair,Hair, Fetal,Lanugo,Fetal Hairs,Hairs,Hairs, Fetal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Lena-Maria Mehling, and Xin Wang, and Sys-Stybe Johansen, and Annika Spottke, and Anna Heidbreder, and Peter Young, and Burkhard Madea, and Cornelius Hess
May 2017, Forensic science international,
Lena-Maria Mehling, and Xin Wang, and Sys-Stybe Johansen, and Annika Spottke, and Anna Heidbreder, and Peter Young, and Burkhard Madea, and Cornelius Hess
August 1998, Sleep,
Lena-Maria Mehling, and Xin Wang, and Sys-Stybe Johansen, and Annika Spottke, and Anna Heidbreder, and Peter Young, and Burkhard Madea, and Cornelius Hess
July 2023, Drug testing and analysis,
Lena-Maria Mehling, and Xin Wang, and Sys-Stybe Johansen, and Annika Spottke, and Anna Heidbreder, and Peter Young, and Burkhard Madea, and Cornelius Hess
April 2015, Forensic science international,
Lena-Maria Mehling, and Xin Wang, and Sys-Stybe Johansen, and Annika Spottke, and Anna Heidbreder, and Peter Young, and Burkhard Madea, and Cornelius Hess
October 2016, Scientific reports,
Lena-Maria Mehling, and Xin Wang, and Sys-Stybe Johansen, and Annika Spottke, and Anna Heidbreder, and Peter Young, and Burkhard Madea, and Cornelius Hess
February 2006, Fa yi xue za zhi,
Lena-Maria Mehling, and Xin Wang, and Sys-Stybe Johansen, and Annika Spottke, and Anna Heidbreder, and Peter Young, and Burkhard Madea, and Cornelius Hess
January 2000, Alcohol and alcoholism (Oxford, Oxfordshire),
Lena-Maria Mehling, and Xin Wang, and Sys-Stybe Johansen, and Annika Spottke, and Anna Heidbreder, and Peter Young, and Burkhard Madea, and Cornelius Hess
May 2015, Drug testing and analysis,
Lena-Maria Mehling, and Xin Wang, and Sys-Stybe Johansen, and Annika Spottke, and Anna Heidbreder, and Peter Young, and Burkhard Madea, and Cornelius Hess
August 2021, Forensic science international,
Lena-Maria Mehling, and Xin Wang, and Sys-Stybe Johansen, and Annika Spottke, and Anna Heidbreder, and Peter Young, and Burkhard Madea, and Cornelius Hess
October 2018, Molecules (Basel, Switzerland),
Copied contents to your clipboard!